| Rank | Company | Cash on hand | Sector | Industry | Country | Exchange |
|---|---|---|---|---|---|---|
| 201 | $214M | Healthcare | Medical Devices | United States | Nasdaq | |
| 202 | $214M | Healthcare | Medical Instruments & Supplies | United States | Nasdaq | |
| 203 | $212M | Healthcare | Medical Instruments & Supplies | United States | NYSE | |
| 204 | $207M | Healthcare | Medical Devices | United States | Nasdaq | |
| 205 | $206M | Healthcare | Medical Devices | United States | Nasdaq | |
| 206 | $206M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 207 | $205M | Healthcare | Medical Devices | United States | NYSE | |
| 208 | $205M | Healthcare | Biotechnology | United States | Nasdaq | |
| 209 | $205M | Healthcare | Biotechnology | United States | Nasdaq | |
| 210 | $203M | Healthcare | Biotechnology | United States | Nasdaq | |
| 211 | $202M | Healthcare | Biotechnology | United States | Nasdaq | |
| 212 | $202M | Healthcare | Biotechnology | United States | Nasdaq | |
| 213 | $200M | Healthcare | Medical Instruments & Supplies | United States | NYSE | |
| 214 | $199M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 215 | $197M | Healthcare | Diagnostics & Research | United States | Nasdaq | |
| 216 | $197M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 217 | $197M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 218 | $195M | Healthcare | Biotechnology | United States | Nasdaq | |
| 219 | $194M | Healthcare | Healthcare Providers | United States | Nasdaq | |
| 220 | $192M | Healthcare | Diagnostics & Research | United States | NYSE | |
| 221 | $191M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 222 | $191M | Healthcare | Biotechnology | United States | Nasdaq | |
| 223 | $188M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 224 | $185M | Healthcare | Biotechnology | United States | Nasdaq | |
| 225 | $185M | Healthcare | Medical Instruments & Supplies | United States | Nasdaq | |
| 226 | $184M | Healthcare | Healthcare Providers | United States | Nasdaq | |
| 227 | $183M | Healthcare | Biotechnology | United States | Nasdaq | |
| 228 | $182M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 229 | $182M | Healthcare | Healthcare Providers | United States | Nasdaq | |
| 230 | $182M | Healthcare | Biotechnology | United States | Nasdaq | |
| 231 | $181M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 232 | $180M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 233 | $180M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 234 | $180M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 235 | $179M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 236 | $178M | Healthcare | Medical Instruments & Supplies | United States | Nasdaq | |
| 237 | $177M | Healthcare | Medical Devices | United States | Nasdaq | |
| 238 | $176M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 239 | $176M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 240 | $174M | Healthcare | Health Services | United States | NYSE | |
| 241 | $172M | Healthcare | Diagnostics & Research | United States | Nasdaq | |
| 242 | $172M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 243 | $171M | Healthcare | Healthcare Providers | United States | Nasdaq | |
| 244 | $170M | Healthcare | Biotechnology | United States | Nasdaq | |
| 245 | $170M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 246 | $169M | Healthcare | Healthcare Providers | United States | Nasdaq | |
| 247 | $168M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 248 | $168M | Healthcare | Medical Devices | United States | Nasdaq | |
| 249 | $167M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 250 | $166M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 251 | $165M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 252 | $164M | Healthcare | Healthcare Providers | United States | NYSE | |
| 253 | $164M | Healthcare | Health Services | United States | NYSE | |
| 254 | $163M | Healthcare | Biotechnology | United States | Nasdaq | |
| 255 | $162M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 256 | $161M | Healthcare | Medical Devices | United States | Nasdaq | |
| 257 | $160M | Healthcare | Biotechnology | United States | Nasdaq | |
| 258 | $160M | Healthcare | Medical Instruments & Supplies | United States | NYSE | |
| 259 | $159M | Healthcare | Biotechnology | United States | Nasdaq | |
| 260 | $158M | Healthcare | Healthcare Providers | United States | NYSE | |
| 261 | $156M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 262 | $155M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 263 | $155M | Healthcare | Biotechnology | United States | Nasdaq | |
| 264 | $155M | Healthcare | Medical Instruments & Supplies | United States | Nasdaq | |
| 265 | $155M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 266 | $153M | Healthcare | Healthcare Providers | United States | Nasdaq | |
| 267 | $150M | Healthcare | Pharmaceuticals | United States | NYSE | |
| 268 | $149M | Healthcare | Healthcare Providers | United States | NYSE | |
| 269 | $149M | Healthcare | Medical Instruments & Supplies | United States | Nasdaq | |
| 270 | $148M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 271 | $145M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 272 | $145M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 273 | $143M | Healthcare | Biotechnology | United States | Nasdaq | |
| 274 | $143M | Healthcare | Biotechnology | United States | Nasdaq | |
| 275 | $142M | Healthcare | Healthcare Providers | United States | NYSE | |
| 276 | $140M | Healthcare | Pharmaceuticals | United States | NYSE | |
| 277 | $139M | Healthcare | Healthcare Providers | United States | NYSE | |
| 278 | $138M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 279 | $138M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 280 | $136M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 281 | $136M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 282 | $136M | Healthcare | Biotechnology | United States | Nasdaq | |
| 283 | $136M | Healthcare | Medical Devices | United States | Nasdaq | |
| 284 | $136M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 285 | $135M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 286 | $134M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 287 | $133M | Healthcare | Biotechnology | United States | Nasdaq | |
| 288 | $133M | Healthcare | Medical Instruments & Supplies | United States | Nasdaq | |
| 289 | $130M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 290 | $129M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 291 | $128M | Healthcare | Medical Devices | United States | NYSE | |
| 292 | $128M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 293 | $126M | Healthcare | Biotechnology | United States | Nasdaq | |
| 294 | $126M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 295 | $125M | Healthcare | Biotechnology | United States | Nasdaq | |
| 296 | $125M | Healthcare | Biotechnology | United States | Nasdaq | |
| 297 | $125M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 298 | $125M | Healthcare | Medical Instruments & Supplies | United States | NYSE | |
| 299 | $124M | Healthcare | Biotechnology | United States | Nasdaq | |
| 300 | $123M | Healthcare | Healthcare Providers | United States | Nasdaq |